Journal article
Mitochondrial Calpain-1 Disrupts ATP Synthase and Induces Superoxide Generation in Type 1 Diabetic Hearts: A Novel Mechanism Contributing to Diabetic Cardiomyopathy
Diabetes (New York, N.Y.), Vol.65(1), pp.255-268
01/2016
DOI: 10.2337/db15-0963
PMCID: PMC4686953
PMID: 26470784
Abstract
Calpain plays a critical role in cardiomyopathic changes in type 1 diabetes (T1D). This study investigated how calpain regulates mitochondrial reactive oxygen species (ROS) generation in the development of diabetic cardiomyopathy. T1D was induced in transgenic mice overexpressing calpastatin, in mice with cardiomyocyte-specific capn4 deletion, or in their wild-type littermates by injection of streptozotocin. Calpain-1 protein and activity in mitochondria were elevated in diabetic mouse hearts. The increased mitochondrial calpain-1 was associated with an increase in mitochondrial ROS generation and oxidative damage and a reduction in ATP synthase-α (ATP5A1) protein and ATP synthase activity. Genetic inhibition of calpain or upregulation of ATP5A1 increased ATP5A1 and ATP synthase activity, prevented mitochondrial ROS generation and oxidative damage, and reduced cardiomyopathic changes in diabetic mice. High glucose concentration induced ATP synthase disruption, mitochondrial superoxide generation, and cell death in cardiomyocytes, all of which were prevented by overexpression of mitochondria-targeted calpastatin or ATP5A1. Moreover, upregulation of calpain-1 specifically in mitochondria induced the cleavage of ATP5A1, superoxide generation, and apoptosis in cardiomyocytes. In summary, calpain-1 accumulation in mitochondria disrupts ATP synthase and induces ROS generation, which promotes diabetic cardiomyopathy. These findings suggest a novel mechanism for and may have significant implications in diabetic cardiac complications.
Details
- Title: Subtitle
- Mitochondrial Calpain-1 Disrupts ATP Synthase and Induces Superoxide Generation in Type 1 Diabetic Hearts: A Novel Mechanism Contributing to Diabetic Cardiomyopathy
- Creators
- Rui Ni - Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu Province, China Department of Medicine, Lawson Health Research Institute, University of Western Ontario, London, Ontario, Canada Department of Pathology, Lawson Health Research Institute, University of Western Ontario, London, Ontario, CanadaDong Zheng - Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu Province, China Department of Medicine, Lawson Health Research Institute, University of Western Ontario, London, Ontario, Canada Department of Pathology, Lawson Health Research Institute, University of Western Ontario, London, Ontario, CanadaSidong Xiong - Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu Province, ChinaDavid J Hill - Department of Medicine, Lawson Health Research Institute, University of Western Ontario, London, Ontario, CanadaTao Sun - Department of Medicine, Lawson Health Research Institute, University of Western Ontario, London, Ontario, CanadaRichard B Gardiner - Department of Biology, Lawson Health Research Institute, University of Western Ontario, London, Ontario, CanadaGuo-Chang Fan - Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OHYanrong Lu - Key Laboratory of Transplant Engineering and Immunology, Ministry of Health, Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, ChinaE Dale Abel - Division of Endocrinology and Metabolism, Fraternal Order of Eagles Diabetes Research Center, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IAPeter A Greer - Division of Cancer Biology and Genetics, Queen's University Cancer Research Institute, and Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, CanadaTianqing Peng - Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu Province, China Department of Medicine, Lawson Health Research Institute, University of Western Ontario, London, Ontario, Canada Department of Pathology, Lawson Health Research Institute, University of Western Ontario, London, Ontario, Canada tpeng2@uwo.ca
- Resource Type
- Journal article
- Publication Details
- Diabetes (New York, N.Y.), Vol.65(1), pp.255-268
- Publisher
- United States
- DOI
- 10.2337/db15-0963
- PMID
- 26470784
- PMCID
- PMC4686953
- ISSN
- 0012-1797
- eISSN
- 1939-327X
- Grant note
- MOP-133657 / Canadian Institutes of Health Research R01-HL-087861 / NHLBI NIH HHS R01 GM112930 / NIGMS NIH HHS R01 HL087861 / NHLBI NIH HHS
- Language
- English
- Date published
- 01/2016
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Fraternal Order of Eagles Diabetes Research Center; Biochemistry and Molecular Biology; Endocrinology and Metabolism; Internal Medicine
- Record Identifier
- 9984024546002771
Metrics
9 Record Views